LV11432B - Combination of bisphosphonates and growth hormone secretagogues - Google Patents
Combination of bisphosphonates and growth hormone secretagogues Download PDFInfo
- Publication number
- LV11432B LV11432B LVP-96-124A LV960124A LV11432B LV 11432 B LV11432 B LV 11432B LV 960124 A LV960124 A LV 960124A LV 11432 B LV11432 B LV 11432B
- Authority
- LV
- Latvia
- Prior art keywords
- aryl
- group
- amino
- alkyl
- carbonyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13929693A | 1993-10-19 | 1993-10-19 | |
US25909194A | 1994-06-13 | 1994-06-13 | |
PCT/US1994/011912 WO1995011029A1 (en) | 1993-10-19 | 1994-10-18 | Combination of bisphosphonates and growth hormone secretagogues |
Publications (2)
Publication Number | Publication Date |
---|---|
LV11432A LV11432A (lv) | 1996-08-20 |
LV11432B true LV11432B (en) | 1996-12-20 |
Family
ID=26837073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-96-124A LV11432B (en) | 1993-10-19 | 1996-04-23 | Combination of bisphosphonates and growth hormone secretagogues |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0813414A4 (no) |
JP (1) | JPH09504525A (no) |
KR (1) | KR960705575A (no) |
CN (1) | CN1136278A (no) |
AU (1) | AU8083694A (no) |
BG (1) | BG100517A (no) |
BR (1) | BR9407869A (no) |
CA (1) | CA2173333A1 (no) |
CZ (1) | CZ109196A3 (no) |
FI (1) | FI961681A (no) |
HU (1) | HUT75224A (no) |
LV (1) | LV11432B (no) |
NO (1) | NO961536L (no) |
PL (1) | PL314003A1 (no) |
SK (1) | SK49796A3 (no) |
WO (1) | WO1995011029A1 (no) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686624A (en) * | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
US20020111461A1 (en) | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
EP0828754B1 (en) * | 1995-05-29 | 2005-02-02 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
AU7522896A (en) * | 1995-10-27 | 1997-05-15 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
ES2268713T3 (es) | 1995-12-13 | 2007-03-16 | MERCK & CO., INC. | Ensayos de receptores de secretagogos de la hormona de crecimiento. |
US6531314B1 (en) | 1996-12-10 | 2003-03-11 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
IL126983A0 (en) * | 1996-05-31 | 1999-09-22 | Novo Nordisk As | Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
AU4993497A (en) * | 1996-10-25 | 1998-05-22 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
US6376477B2 (en) | 1996-11-25 | 2002-04-23 | Merck & Co., Inc. | Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism |
GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
ZA987385B (en) * | 1997-08-19 | 2000-04-18 | Lilly Co Eli | Growth hormone secretagogues. |
US6211174B1 (en) * | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
IT1296495B1 (it) * | 1997-11-21 | 1999-06-25 | Prodotti Antibiotici Spa | Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare |
US6682908B1 (en) | 1998-07-10 | 2004-01-27 | Merck & Co., Inc. | Mouse growth hormone secretagogue receptor |
CA2333857A1 (en) | 1998-07-13 | 2000-01-20 | Merck & Co., Inc. | Growth hormone secretagogue related receptors and nucleic acids |
EP1112282A4 (en) | 1998-08-10 | 2002-10-31 | Merck & Co Inc | RECEPTOR OF THE GROWTH HORMONE SECRETION PROMOTER FROM THE DOG |
EP1112071A4 (en) * | 1998-08-18 | 2003-03-19 | Lilly Co Eli | SECRETAGOGUES OF GROWTH HORMONES |
US6639076B1 (en) | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
AR013994A1 (es) * | 1998-10-30 | 2001-01-31 | Gador Sa | Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes. |
AU1525700A (en) * | 1998-11-19 | 2000-06-05 | Board Of Trustees Of The University Of Arkansas, The | Increasing bone strength with selected bisphosphonates |
US6828331B1 (en) | 1999-02-19 | 2004-12-07 | Eli Lilly And Company | Growth hormone secretagogues |
WO2000074685A1 (fr) * | 1999-06-02 | 2000-12-14 | Sumitomo Pharmaceuticals Co., Ltd. | Preparations orales d'etidronate disodique |
ES2333097T3 (es) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
US6548042B2 (en) | 2000-08-07 | 2003-04-15 | Arstad Erik | Bis-phosphonate compounds |
DK1372669T3 (da) | 2001-01-23 | 2005-10-17 | Gador Sa | Bisphosphonatholding sammensætning til forebyggelse og/eller behandling af metaboliske knoglesygdomme, fremgangsmåde til fremstilling af sådanne sammensætninger og anvendelse deraf |
US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
WO2003087070A2 (en) | 2002-04-09 | 2003-10-23 | Eli Lilly And Company | Growth hormone secretagogues |
GB0213715D0 (en) | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
DK1622630T3 (da) * | 2003-05-07 | 2012-12-17 | Osteologix As | P009368epdk1 |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
EP2364705A3 (en) | 2004-08-19 | 2012-04-04 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
MX2007006382A (es) | 2004-11-29 | 2007-07-11 | Vertex Pharma | Moduladores de receptores muscarinicos. |
US7858635B2 (en) | 2005-12-22 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Spiro compounds as modulators of muscarinic receptors |
WO2007100670A1 (en) | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Spiro condensed piperidnes as modulators of muscarinic receptors |
AU2007221214A1 (en) | 2006-02-22 | 2007-09-07 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
US7858790B2 (en) | 2006-06-29 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
US7696201B2 (en) | 2006-08-15 | 2010-04-13 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
AU2007284350A1 (en) | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
US20100099640A1 (en) | 2007-05-04 | 2010-04-22 | Joannes Geuns | Tissue degeneration protection |
WO2009045519A1 (en) | 2007-10-03 | 2009-04-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
KR20160147007A (ko) | 2014-05-30 | 2016-12-21 | 화이자 인코포레이티드 | 선택적인 안드로겐 수용체 조절제로서의 카보니트릴 유도체 |
US11981909B2 (en) | 2018-06-06 | 2024-05-14 | Massachusetts Institute Of Technology | Circular RNA for translation in eukaryotic cells |
SG11202112922WA (en) | 2019-05-22 | 2021-12-30 | Massachusetts Inst Technology | Circular rna compositions and methods |
EP3920976B1 (en) | 2019-12-04 | 2023-07-19 | Orna Therapeutics, Inc. | Circular rna compositions and methods |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU569391B2 (en) * | 1984-04-30 | 1988-01-28 | Procter & Gamble Company, The | Treating osteoporosis |
AU568433B2 (en) * | 1984-04-30 | 1987-12-24 | Procter & Gamble Company, The | Treating osteoporosis |
CZ151495A3 (en) * | 1992-12-11 | 1995-12-13 | Merck & Co Inc | Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof |
US5284841A (en) * | 1993-02-04 | 1994-02-08 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
US5434261A (en) * | 1993-07-26 | 1995-07-18 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
US5545735A (en) * | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
-
1994
- 1994-10-18 HU HU9601013A patent/HUT75224A/hu unknown
- 1994-10-18 BR BR9407869A patent/BR9407869A/pt not_active Application Discontinuation
- 1994-10-18 CN CN94194311A patent/CN1136278A/zh active Pending
- 1994-10-18 KR KR1019960702007A patent/KR960705575A/ko not_active Application Discontinuation
- 1994-10-18 JP JP7512182A patent/JPH09504525A/ja active Pending
- 1994-10-18 WO PCT/US1994/011912 patent/WO1995011029A1/en not_active Application Discontinuation
- 1994-10-18 AU AU80836/94A patent/AU8083694A/en not_active Abandoned
- 1994-10-18 PL PL94314003A patent/PL314003A1/xx unknown
- 1994-10-18 CZ CZ961091A patent/CZ109196A3/cs unknown
- 1994-10-18 SK SK497-96A patent/SK49796A3/sk unknown
- 1994-10-18 CA CA002173333A patent/CA2173333A1/en not_active Abandoned
- 1994-10-18 EP EP94931923A patent/EP0813414A4/en not_active Withdrawn
-
1996
- 1996-04-17 FI FI961681A patent/FI961681A/fi unknown
- 1996-04-18 BG BG100517A patent/BG100517A/xx unknown
- 1996-04-18 NO NO961536A patent/NO961536L/no unknown
- 1996-04-23 LV LVP-96-124A patent/LV11432B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH09504525A (ja) | 1997-05-06 |
LV11432A (lv) | 1996-08-20 |
WO1995011029A1 (en) | 1995-04-27 |
EP0813414A1 (en) | 1997-12-29 |
BG100517A (en) | 1996-11-29 |
NO961536L (no) | 1996-06-18 |
CN1136278A (zh) | 1996-11-20 |
CA2173333A1 (en) | 1995-04-27 |
HUT75224A (en) | 1997-04-28 |
AU8083694A (en) | 1995-05-08 |
FI961681A0 (fi) | 1996-04-17 |
BR9407869A (pt) | 1996-10-29 |
KR960705575A (ko) | 1996-11-08 |
NO961536D0 (no) | 1996-04-18 |
EP0813414A4 (en) | 1999-07-21 |
PL314003A1 (en) | 1996-08-05 |
CZ109196A3 (en) | 1996-10-16 |
HU9601013D0 (en) | 1996-06-28 |
SK49796A3 (en) | 1997-05-07 |
FI961681A (fi) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV11432B (en) | Combination of bisphosphonates and growth hormone secretagogues | |
DE69332075T2 (de) | Spiropiperidine and ihre Homologen, die die Ausschüttung von Wachstumshormonen stimulieren | |
US5578593A (en) | Spiro piperidines and homologs promote release of growth hormone | |
CA2134149A1 (en) | Compounds containing a fused multiple ring lactam | |
SK56296A3 (en) | Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them | |
WO1996002530A1 (en) | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone | |
WO1997041878A1 (en) | Treatment of mood disorders with a growth hormone secretagogue | |
AU2867899A (en) | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders | |
AU1045395A (en) | Benzo-fused macrocycles promote release of growth hormone | |
EP0662481B1 (en) | Spiro piperidines and homologs promote release of growth hormone | |
WO1997036873A1 (en) | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone | |
EP0728746B1 (en) | Azepinone compounds useful in the inhibition of ACE and NEP | |
KR20010023656A (ko) | 골 대사성 질환의 치료를 위한 아르기닌 모의체를함유하는 펩타이드, 그의 제조 방법, 및 이를 함유한 약제 | |
WO1997011697A1 (en) | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone | |
WO1998025897A1 (en) | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone | |
EP0500989B1 (en) | N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents | |
JP4679778B2 (ja) | アミドスピロピペリジン類による成長ホルモン放出の促進 | |
US5308841A (en) | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE | |
AU670866B2 (en) | Phosphonomethyldipeptides | |
EP0186431B1 (en) | Anti-hypertensive octahydro-6-azaindole dipeptide derivatives | |
JPH08225586A (ja) | 新規リン酸誘導体、その製造法およびそれを含有する医薬組成物 |